Guidelines for Follow‐Up of Women at High Risk for Inherited Breast Cancer: Consensus Statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer
Open Access
- 1 January 1999
- journal article
- research article
- Published by Wiley in Disease Markers
- Vol. 15 (1-3) , 207-211
Abstract
Protocols for activity aiming at early diagnosis and treatment of inherited breast or breast‐ovarian cancer have been reported. Available reports on outcome of such programmes are considered here. It is concluded that the ongoing activities should continue with minor modifications. Direct evidence of a survival benefit from breast and ovarian screening is not yet available. On the basis of expert opinion and preliminary results from intervention programmes indicating good detection rates for early breast cancers and 5‐year survival concordant with early diagnosis, we propose that women at high risk for inherited breast cancer be offered genetic counselling, education in ‘breast awareness’ and annual mammography and clinical expert examination from around 30 years of age. Mammography every second year may be sufficient from 60 years on. BRCA1 mutation carriers may benefit from more frequent examinations and cancer risk may be reduced by oophorectomy before 40–50 years of age. We strongly advocate that all activities should be organized as multicentre studies subjected to continuous evaluation to measure the effects of the interventions on long‐term mortality, to match management options more precisely to individual risks and to prepare the ground for studies on chemoprevention.Keywords
This publication has 15 references indexed in Scilit:
- Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation CarriersJNCI: Journal of the National Cancer Institute, 1999
- Penetrances of BRCA1 1675delA and 1135insA with Respect to Breast Cancer and Ovarian CancerThe American Journal of Human Genetics, 1999
- Uptake of Genetic Testing and Pre‐Test Levels of Mental Distress in Norwegian Families with Known BRCA1 MutationsDisease Markers, 1999
- BRCA1 1675delA and 1135insA Account for One Third of Norwegian Familial Breast‐Ovarian Cancer and Are Associated with Later Disease Onset than Less Frequent MutationsDisease Markers, 1999
- Recommendations for medical management of hereditary breast and ovarian cancer: The French National Ad Hoc CommitteeAnnals of Oncology, 1998
- Oral Contraceptives and the Risk of Hereditary Ovarian CancerNew England Journal of Medicine, 1998
- Multifactorial Analysis of Differences Between Sporadic Breast Cancers and Cancers Involving BRCA1 and BRCA2 MutationsJNCI: Journal of the National Cancer Institute, 1998
- Screening women aged less than 50 years with a family history of breast cancerEuropean Journal of Cancer, 1998
- Screening by mammography, women with a family history of breast cancerEuropean Journal of Cancer, 1998
- Prospective findings in breast cancer kindreds: annual incidence rates according to age, stage at diagnosis, mean sojourn time, and incidence rates for contralateral cancerThe Breast, 1998